Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) -- In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications...

Global Gastrointestinal Drugs Market Report (2021 to 2030) - COVID-19 Implications and Growth Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Gastrointestinal Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....

Medical Abortions Four Times as Risky as Surgical, Reports the Journal of American Physicians and Surgeons TUCSON, Ariz., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Abortion providers are encouraging women to choose the medical abortion option, but studies consistently show that the rate of complications is four...